NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Tags: stem cells

This page is for our PR news release reviews tagged under “stem cells.”

10/24/2017

Stem cell procedure marketed for erectile dysfunction, with no evidence

5/26/2017

Examining stem cell activity in petri dishes and in rats doesn’t put us in shouting distance of a treatment for tendons

2/7/2017

NIH gives crisp summary of early stem cell transplants for multiple sclerosis, but missed some limitations

12/12/2016

Mayo Clinic touts ‘dramatic improvement’ in ‘surprising’ stem cell therapy study; yet placebo performed equally well

6/3/2016

PR release on CD34+ stem cell treatment for angina raises multiple red flags

4/21/2015

Eye stem cell treatment in people may not be as close as rat study release suggests

News Release Reviews

Systematic, Criteria-Driven

@HealthNewsRevu

HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

.@TranspariMED criticizes STAT op-ed for not disclosing pharma funding of author’s institute - similar to criticism we’ve made of STAT op-eds in the past. @transparify @ThinkTankWatch @icer_review https://www.healthnewsreview.org/2021/02/transparency-watchdog-criticizes-stats-non-disclosure-on-pro-pharma-op-ed/

Reply on Twitter 1360214949704982532Retweet on Twitter 13602149497049825323Like on Twitter 13602149497049825328Twitter 1360214949704982532
Retweet on TwitterHealthNewsReview.org Retweeted
ContentScienceContent Science@ContentScience·

If you’re covering COVID-19, you need a robust understanding of how to report on health and science news (and when you're in over your head). Get a leg up with these insights from @garyschwitzer.

https://review.content-science.com/health-and-science-communication-in-the-covid-era-a-qa-with-the-publisher-of-health-news-review/

Reply on Twitter 1359955873561518085Retweet on Twitter 13599558735615180852Like on Twitter 13599558735615180851Twitter 1359955873561518085
HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

Tech sites @MacRumors & @TechCrunch hype #AppleWatch’s ability to predict #COVID19 without providing the evidence. @mtmdphd was keen observer. https://www.healthnewsreview.org/2021/02/tech-sites-hype-apple-watch-for-covid-19-prediction-without-providing-the-evidence/

Reply on Twitter 1359860468135964683Retweet on Twitter 13598604681359646832Like on Twitter 13598604681359646834Twitter 1359860468135964683
View More

Categories

View More

Tags